'Sinovac Vaccine Probably Won't Arrive Next Month'
"); jQuery("#212 h3").html("

"); jQuery(document).ready(function() { jwplayer.key='EKOtdBrvhiKxeOU807UIF56TaHWapYjKnFiG7ipl3gw='; var playerInstance = jwplayer("jquery_jwplayer_1"); playerInstance.setup({ file: "https://newsstatic.rthk.hk/audios/mfile_1566925_1_20201224181337.mp3", skin: { url: location.href.split('/', 4).join('/') + '/jwplayer/skin/rthk/five.css', name: 'five' }, hlshtml: true, width: "100%", height: 30, wmode: 'transparent', primary: navigator.userAgent.indexOf("Trident")>-1 ? "flash" : "html5", events: { onPlay: function(event) { dcsMultiTrack('DCS.dcsuri', 'https://news.rthk.hk/rthk/en/component/k2/1566925-20201224.mp3', 'WT.ti', ' Audio at newsfeed', 'WT.cg_n', '#rthknews', 'WT.cg_s', 'Multimedia','WT.es','https://news.rthk.hk/rthk/en/component/k2/1566925-20201224.htm', 'DCS.dcsqry', '' ); } } }); }); });
2020-12-24 HKT 11:42
A government adviser on the pandemic said on Thursday that there will likely be a month's delay for Sinovac's vaccine to reach Hong Kong, as reports said the release of the jab's latest trial results in Brazil is being pushed back.
The mainland vaccine manufacturer was originally expected to publish its vaccine's phase three efficacy data around Wednesday, but it has now asked for the release to be put back by up to 15 days so that it can analyse the data from Brazil alongside that collected in Indonesia and Turkey.
Brazilian researchers said on Wednesday that preliminary data suggests Sinovac jabs are "more than 50 percent effective".
Health Secretary Sophia Chan had previously expected Hong Kong to get hold of the vaccine in January and have people injected by February or March.
But Chinese University's Professor David Hui said on a radio programme that the jabs will probably arrive only in February, adding that the BioNTech/Fosun Pharma vaccine may be the first available in the city.
Meanwhile, University of Hong Kong microbiologist Ho Pak-leung played down concerns over Sinovac’s delay in announcing the latest clinical data.
“For mainland vaccines, relevant departments like the National Medical Products Administration have tight supervision over the production and other areas,” he told an RTHK programme.
He added that the technology used by Sinovac to make the vaccine is mature.
But he urged the government to keep pushing for more information on the vaccine's efficacy on mutated coronavirus strains. (Additional reporting by Reuters)
Tencent Officially Launches T1 Reasoning Model In Chinas Competitive AI Landscape
Tencent has officially unveiled its T1 reasoning model, marking a significant step forward in the increasingly competit... Read more
Ping An Insurance Achieves A 47.8% Rise In 2024 Net Profit
Ping An Insurance (Group) Company of China, Ltd. (Ping An) announced on 19 March 2025 its financial results for the yea... Read more
HashKey Capital Secures Type 1 Licence From SFC, Grows Crypto Services In HK
On 18 March 2025, HashKey Capital received a Type 1 licence from the Hong Kong Securities and Futures Commission (SFC),... Read more
Ping An P&C And FAW Hongqi Launch Hongqi Intelligent Driving Protection Services
Ping An Property & Casualty Insurance Company of China (Ping An P&C), a subsidiary of Ping An Insurance, has pa... Read more
HKSTP European Innovation Mixer Tour Nurtures Global Ties For Hong Kong
The Hong Kong Science and Technology Parks Corporation (HKSTP), led by CEO Albert Wong, conducted the HKSTP European In... Read more
The Full List Of Fintech Unicorns In Hong Kong (2025)
Hong Kong’s fintech landscape has evolved into a dynamic force in Asia, driven by regulatory innovation, technologica... Read more